NICE now recommends SGLT2 inhibitors, as well as metformin, as first-line therapy for type II diabetes in final guidance published today.
Get updates from Mims 2014 Home RSS Feed via email, on your phone or read them on follow.it on your own custom news page.
You can filter the news from Mims 2014 Home RSS Feed that get delivered to you using tags or topics or you can opt for all of them. Unsubscription is also very simple.
See the latest news from Mims 2014 Home RSS Feed below.
Site title: Database of prescription and generic drugs, clinical guidelines | MIMS online